The global pandemic is not holding back a leading pharma from progressing its S/4HANA global implementation plans. Enabled by a world-class internal team, Eli Lilly’s innovation roadmap includes pre-projects to reduce migration complexity and leveraging SNP’s BLUEFIELD™ approach to selectively migrate company codes with limited historical data while avoiding a large NewGL activation project. BLUEFIELD™ also significantly reduces risk for this single global cutover event. Hear from Eli Lilly’s Chief SAP Architect on its vision and selection considerations for an automated data-migration platform to deliver this project.